Carter's Inc.
$30.43
The Read: CRI's stock rallied on positive 2026 guidance and strategic initiatives after a neutral earnings report, then surged further on a Q4 earnings beat and restructuring validation, dipped on tariff concerns, and rebounded with strong Q2 results and raised sales outlooks.
CRI
Hover to view data
No Data
